Foot and Mouth Disease (FMD) Vaccine Market Size & Forecast Report, 2014 - 2025

Global Foot and Mouth Disease (FMD) Vaccine Market is anticipated to reach USD 3.0 billion by 2025. Foot-and-Mouth Disease also termed as “Hoof-and-Mouth Disease” implies an infectious and contagious viral disease that affects cloven-hoofed animals, involving wild and domestic bovids. The after-effects of foot and mouth disease include a high fever that lasts for two to six days. The symptoms include blisters on the feet and inside the mouth. Foot and Mouth Disease (FMD) Vaccine has a significant economic impact.

The factors that propel the growth of the market include changing lifestyle coupled with a change in food preference, increasing awareness among people, and increased acceptance of oil-based vaccines due to their developed effectiveness. On the other hand, some factors may hamper the growth of the market such as less immunity, high cost, instability at room temperature (3-8°C). Foot and Mouth Disease Vaccine Market is anticipated to grow at a significant CAGR of 8.1% in the upcoming period as the scope, product types, and applications are increasing across the globe.

Foot and Mouth Disease (FMD) Vaccine Industry may be explored by product type, application, and geography. The market may be explored by product type as Conventional vaccines, and Emergency vaccines. The “Conventional vaccines” section dominated the FMD Vaccine Market in 2016 and is anticipated to maintain its dominance by 2025 owing to the increasing penetration of oil-based vaccines due to their higher efficacy and long-term effectiveness.

Foot and Mouth Disease (FMD) Vaccine Market may be explored by application as Sheep and Goats, Cattle, and Pigs. The “Cattle” section dominated the Foot and Mouth Disease Vaccine industry in 2016 and is anticipated to maintain its dominance by 2025 owing to improved demand for livestock products. Asia-Pacific accounted for the major share of the Foot and Mouth Disease (FMD) Vaccine Market Size in 2016 and will continue to lead in the forthcoming period. The factors that could attribute to the growth include growing R&D investment. Asia-Pacific is followed by North America.

Some of the key players that fuel the growth of the Foot and Mouth Disease (FMD) Vaccine industry comprise Ceva, SEPPIC, Bayer HealthCare, Inovio Pharmaceuticals, Plumbline Life Sciences, Merck, BiogénesisBagó, Indian Immunologicals, Brilliant Bio Pharma, Boehringer Ingelheim. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures to increase the inorganic growth of the industry.

Market Segment:

Technique Outlook (Revenue, USD Million, 2014 - 2025)
    • Conventional vaccines
        • Aluminum hydroxide/Saponin-based vaccines
        • Oil-based vaccines
    • Emergency vaccines

Animal Type Outlook (Revenue, USD Million, 2014 - 2025)
    • Cattle
    • Sheep and Goat
    • Pigs
    • Others (antelope, deer, bison, camelids)

Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
    • Europe
    • the Asia Pacific
        • India
        • China
        • Japan
        • Malaysia
    • South Korea
        • Latin America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa
        • Nigeria
        • Saudi Arabia